MANE
Veradermics, Incorporated
Stock
$116.76−0.46 (−0.39%)Close Oct 2, 2026
- Capital expenditures, 2025
- $24K
Capital expenditures
Capital expenditures by fiscal year
| Period | Capex | YoY |
|---|---|---|
| 2025 | $24K | — |
| 2024 | $0 | — |
Veradermics, Incorporated
$116.76−0.46 (−0.39%)Close Oct 2, 2026
| Period | Capex | YoY |
|---|---|---|
| 2025 | $24K | — |
| 2024 | $0 | — |